Proud to be supporting the EDIS initiative. Join our Clinical Development Operations Leader, Peju Oshisanya on 9th September where she'll be discussing the importance of diversity in clinical trials and AI
Research to improve human health should aim to create equal and better health outcomes, from biomedical research through to clinical trials. This symposium will take the concepts of Equality, Diversity and Inclusion and look at how these are applicable to research and experimental design, aiming to investigate ideas around the sex of cells and animals used in research, the ethnicity and ancestry of participants in genome sequencing projects, the diversity of participants in clinical trials and inclusive public involvement in research.
An innovative operational strategy expert with extensive and wide-ranging experience relating to strategic programme leadership, planning and management of clinical trials with responsibility for global clinical programmes (US, Europe and Japan). Peju started her career working in early drug discovery and exploratory phase focused on the transition of early stage assets to clinical development. Following this, she moved into programme management of late stage assets responsible for key clinical programmes within Eli Lilly, Sanofi Aventis, Pfizer and Takeda before joining BenevolentAI as Clinical Development Operations Leader